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ABSTRACT 
Tablet is a solid dosage form which is used to deliver the drug to the body to make pharmacological action. The oral dosage form should 
disperse into small particles to deliver active ingredients in the body, the disperse time of the dosage form depends on the ingredients which 
are used in the tablet. To make the tablet disintegrate slow usually sustained release agents are used. The sustained release tablets helps in 
maintaining the drug concentration in the body for the higher time. In this review article various polymers of natural origin and their modified 
forms are studied, which can be used in the sustained release tablet. In this review article the polymers studied were, Psyll ium husk, HPMC 
K100M, Cellulose polymers, Cellulose ether polymers, Xanthan gum, Guar gum, Eudragit RLPO, Eudragit RSPO, Eudragit RL 100, Eudragit RS 
100, Kollidone SR and Carnauba wax. Now a day the sustained release tablets are used more than the conventional tablets because of the 
patient incompliance. The main part of the sustained release tablets are the polymers. In the study it was found that the modified forms of 
natural polymers works better than in their natural form. In the study it was found that the hydrophilic polymers also work better like Xanthan 
gum and Guar gum, they are effecting and non-toxic in nature. The cellulose derivatives were studied and it was found that Substituted 
cellulose-methylcellulose, hydroxypropylcellulose and hydroxypropylmethylcellulose works better in the combination form.  
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INTRODUCTION 
Tablet has always been the most widely used dosage form 
since the ancient time. Now a days different tablet dosage 
forms are available in the markets. The tablets are very easy 
to administer and also they can be taken anywhere, people 
can take the tablets even during travelling [1,3,5]. Most of the 
people forget to take the tablet which results in the 
incomplete action of the drug for a particular disease, so 
now- days the sustained release tablets are used which are 
very convenient to use and also it maintains the drug level in 
the body for a longer time. Hence it can easily use in the 
patient incompliance.  The main mechanism of the sustained 
release tablet is that it releases the drug at the slower rate. In 
other words we usually use the polymers that can retard the 
drug release till the certain period of time [7]. So now we can 
say that the actual time of drug is changed or delayed. In the 
review it is studied that sustained-release dosage forms have 
made significant progress in terms of clinical efficacy and 
patient compliance in past two decades.In the present work 
Preparation of drug-embedded matrix tablet that involves 
the direct compression of a blend of drug, retardant material 
and additives is one of the least complicated approaches for 
delivering drug in a temporal pattern into the systemic 
circulation. The matrix tablet is commonly used for 
manufacturing sustained release dosage forms because it 
makes such manufacturing easy [13]. In the wide array of 
polymers has been employed as drug retarding agents each 
of which presents a different approach to the matrix concept. 
Polymers forming insoluble or skeleton matrices constitute 
the first category of retarding materials, also classed as 
plastic matrix systems. 
There are two classes of polymers hydrophilic and 
hydrophobic in which, the second class represents 
hydrophobic and water-insoluble materials, which is usually 
potentially erodable, while the first group includes polymers 
those form hydrophilic matrices. The matrix systems, due to 
their chemical inertness and drug embedding ability, have 
been widely used for sustaining the release of drug [15]. The 
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liquid penetration into the matrix is the rate-limiting step in 
such systems unless joining agents are used and it can be a 
reason for sustains release property. The hydrophobic and 
waxy materials, on the other hand, are potentially erodable 
and control the release of drug through pore diffusion and 
erosion [16].The hydrophilic matrix systems, when exposed 
to an aqueous medium, does not disintegrate, but 
immediately after hydration develops a highly viscous 
gelatinous surface barrier which controls the drug release 
from and the liquid penetration into the centre of the matrix 
system [18], The purpose work is to evaluate the 
comparative efficiency of abovementioned classes of 
polymers on sustaining the release of active ingredients 
having different physical and chemical properties.  
Kollidone SR 
Kollidone is a chemical substance that is used as a 
pharmaceutical agent to work in a tablet as a sustained 
release agent. Kollidon SR (Polyvinyl acetate and polyvinyl 
pyrrolidone based matrix forming agent), Carnauba wax is a 
waxy material that is obtained from the plant source. It is 
maily found in the South American region. Carnauba wax and 
Hydroxypropyl methyl cellulose (HPMC-15cps) worked as 
hydrophobic and hydrophilic matrix systems respectively. 
Three drugs e.g. atenolol as a soluble neutral drug, diclofenac 
sodium as an acidic drug with pH dependant solubility and 
diltiazem HCl as basic drug of acidic salt works very well 
with these types of polymers. The present study is aimed to 
evaluate the influence of polymer content and polymer type 
on the release profile of drug as well as to establish a 
relationship between drug retaining efficacy of the polymer 
and physic chemical nature of the drug [20].In the study it 
was found that the Carnauba wax causes the strongest 
retardation of drug. On the other hand, highest drug release 
was from matrices however the Kollidon SR gave an 
intermediate release profile between these two polymers. 
The release rate was also found to be the function of physico-
chemical nature of drug molecule. Theophylline and 
diltiazem HCl, being soluble in nature, released faster than 
diclofenac sodium from all matrix systems. The release 
mechanism was explored and explained with bi-exponential 
equation Reza S et al.  
HPMC 
Hydroxypropylmethylcellulose, is derived from the cellulose 
family and it is used to control drug release from several 
pharmaceutical systems because of its non-toxic nature, easy 
compression, swelling properties and accommodation to 
high levels of drug. This cellulose derivative excipient has 
been widely investigated in our laboratory [21]. There are 
lots of research that has been done on HPMC and it always 
says that drug-release processes from both methylcellulose 
and hydroxypropylcellulose better than the other agents in 
case of sustained release dosage form. The sole purpose of 
the present study is to evaluate the effect of polymers on the 
kinetics of the drug release, using distinct formulations, in 
order to understand how they rule this process. It will also 
hopefully allow the design of more suitable cellulose 
matrices. The main part of the diluent is also examined [22]. 
Guar gum 
Guar gum is a natural non-ionic polysaccharide derived from 
the seeds of Cyamopsis tetragonolobus (Family Leguminosae) 
gummy substance. In pharmaceutical products, Guar gum is 
used in solid dosage forms as a binder and disintegrant. The 
naturally occurring guar seed extract which usually contains 
about 80% of galactomannan (guaran), 10% moisture, 5-7% 
protein and trace amounts of heavy metals and ash. It is free 
flowing in nature, completely soluble, neutral polymer and is 
approved for use in food [24]. It is not so sensitive to pH, 
moisture contents or solubility of the tablet matrix. As a 
binding agent, guar gum has been found to be superior to 
some common disintegrants such as corn starch, celluloses, 
alginates and magnesium aluminium silicate. Particle size 
can affect binding properties, with finer particle sizes having 
greater disintegrating capabilities. Guar gum alone could not 
efficiently control the drug release, while Xanthan gum and 
all combinations of natural gums with HPMC could retard 
drug release.The guar gum has shown in Fig. 1. 
 
Fig. 1: Guar gum 
Xanthan Gum 
Xanthan gum is natural, biosynthetic, edible gum and an 
extracellular polysaccharide produced by the bacterium 
Xanthomonas campestris. Xanthan gum consists of glucose, 
mannose, and glucuronic acid [26] and is used in different 
foods as thickener and stabilizer. The main purpose of this 
study was to review matrix sustained-release tablets with 
natural gums (xanthan and guar gum) as suitable hydrophilic 
matrix systems compared with the extensively investigated 
hydrophilic matrices. The Xanthan gum has shown in Fig. 2. 
 
Fig. 2: Xanthan gum 
GUMS IN COMBINATION FORM OR MODIFIED FORM  
It was studied that Different combinations of natural gums 
(guar or xanthan) and also a triple mixture of these polymers 
were used to provide matrix tablets for sustained release of 
water-soluble tramadol HCl. The total 64% of release 
retardant polymer(s) was used in the formulations. It was 
studied that the combination of the gums retained the drug 
release up to 70% than the used alone (Varshosaz et al.)  
Plantago ovata  
Plantago ovatais also known as the isapghula, it is a husk that 
is commonly used as a husk for treating the constipation, due 
to its swelling properties. When it comes in contact with the 
water it get swell. Mucilage of Plantago ovata has various 
properties like binding, disintegrating and sustaining 
properties. The mucilage of the isapghula is used as a super-
disintegrating agent and it’s a very unique technique. To use 
as a super-disintegrant the extraction of the gummy material 
is an essential part. For the extraction the gum, the isapghula 
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seeds are soaked overnight in a Luke warm water, overnight 
the seed releases its all mucilage, after that the mucilage is 
separated from water through muslin cloth. Then it is ready 
to get dry and then it’s sieve under # 40 and placed in 
desiccators. Then store into a well tight container. The rapid 
disintegration of the tablet is due to the swelling of the 
super-disintegrants to create an enough hydrostatic pressure 
to break the tablet. The gum was studied in the dispersible 
tablet and the study showed that the natural gums as 
disintegrants were effective in low (5 %) concentrations 
[30]. During the study it was found that the plantago husk 
works best with the combination chitin. The plantago ovata 
has shown in Fig. 3. 
 
Fig. 3: Plantago ovato 
Chitin or Chitosan  
Chitin is a natural product which is a structural 
polysaccharide. Chitin is widely distributed in nature it 
supports the tissue crustaceans and insects. The chitosan ia 
an deacetylation product of the chitin. That compound is 
non-toxic in nature; recently it has been used in various 
research projects. S Miyuki et al. have utilized the chitosan 
with lactose in sustained release dosage form. The drug and 
chitosan with lactose were dissolved in the solvent followed 
by the distilling off.  The dosage form was studied or 
compared with other sustained release agents and chitosan 
has shown the better result thus, the mixture of chitosan and 
lactose can form sustained release preparation in an acidic 
solution. Since chitosan was gelled to encapsulate the 
medicaments in an acidic solution. The chemical structure of 
the chitosan has shown in Fig. 4. 
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Fig. 4: Chitosan 
Eudragit  
Eudragit is a polymer which is widely used in the 
pharmaceutical industries, eudragit available in the differnet 
grades like eudragit EPO, eudragit RS 100, eudrgit RLPO, 
eudragit RSPO. Patra NC et al has studied the bilayer tablet 
eudrgit RLPO and eudragit RSPO, which were evaluated for 
various physical properties. In the study the bulk densities 
for the granules of various formulations ranged between 
0.87 ± 0.14 and 2.42 ± 0.42 g mL–1, as determined by the tap 
method. It was found that this value of bulk density indicates 
of good packing character. The compressibility index (CI) for 
all the formulations was found to be below 15%, indicating 
desirable flow properties [34]. It was studied that the flow 
properties of granules were quite good; it ranged between 
21.32 ± 0.58 to 25.03 ± 0.23°. The value indicates good flow 
property of granules with Eudragit RLPO and Eudragit RSPO 
as matrix material. Thus, we can say that eudragit works 
quite well in two different grades.  
CONCLUSON  
Form the above observations it is observed that the natural 
and modified forms has their own working capacity in the 
dosage form.  The natural compounds always works the best 
since the natural compounds devoid of the toxicity and 
irritation sensation. But to increase the working capability of 
the product the modified forms are usually used. It was 
studied that the Guar gum alone cannot efficiently control 
drug release, and Xanthan gum has higher drug retarding 
ability than Guar gum. The combination of each natural gum 
with HPMC leads to a greater retarding effect compared with 
a mixture of these natural gums. No synergistic effect has 
been seen for these mixtures of polymers. All combinations 
of guar gum and xanthan with HPMC or xanthan alone can 
retard drug release. It was also concluded that during the 
study the HPMC was studied for the DSC studies as well and 
it was found out that the DSC thermograms alone, it is 
possible to conclude that the selected excipients are likely to 
be suitable for the preparation of tablet formulations, since 
no significative incompatibilities were detected. Even the 
drug: excipient interactions were detected, it was not found 
to affect the drug bioavailability.  
The swelling experiments, shows that the water uptake 
increases with the polymer viscosity, which is a very 
important factor to consider when preparing hydrophilic 
matrix tablets according to the release studies, polymer 
HPMC are not appropriate for the preparation of modified 
ketoprofen hydrophilic matrix tablets, in the conditions 
under study, while HPMC K15M and K100M may be 
advantageous, because it holds the drug for longer time. 
The present research was carried out to study the different 
polymers for the sustained release tablet in the bilayer tablet 
of propranolol hydrochloride using superdisintegrant 
sodium starch glycolate for the fast release layer and 
ethylcellulose, Eudragit RLPO and Eudragit RSPO for the 
sustaining layer it was studied that, Bilayer tablets showed 
an initial burst effect to provide the loading dose of the drug, 
followed by sustained release for 12 h, which indicats that 
the potential of the propranolol hydrochloride bilayer tablet 
as an alternative to the conventional dosage form. 
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